Acreage
OTCMKTS:ACRZFAcreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.
Core One Labs
OTCMKTS:CLABDCore One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. Its focus is to bring psychedelic medicines to market through novel delivery systems and psychotherapy. The firm offers isogenics, cultivation, extraction and distillation, consulting, cannastrips, and quality and control. The company was founded on September 14, 2010 and is headquartered in Vancouver, Canada.
Costa Group
OTCMKTS:CTTQFCosta Group Holdings Limited produces, packs, and markets fruits and vegetables to food retailers. It operates through three segments: Produce, Costa Farms and Logistics, and International. Produce segment engages in farming, packing, and marketing of berries, mushrooms, glasshouse grown tomatoes, citrus, and avocados and bananas primarily to food retailers. Its Costa Farms and Logistics segment operates logistics, wholesale, and marketing services including warehousing and ripening facilities, and trading within Australia. International segment engages in licensing blueberry varieties in Australia, the Americas, China, Africa, and internationally; and berry farming activities in Morocco and China. It also exports its products. The company was founded in 1888 and is headquartered in Docklands, Australia.
Ultra Brands
OTCMKTS:FLLLFUltra Brands Ltd. operates as an agri-food holdings company. It offers vegan dairy substitute products, plant-based chicken, pork, and beef products, including chicken tenders, chicken nuggets, pork cutlets, beef burgers, and other products. The company was formerly known as Feel Foods Ltd. and changed its name to Ultra Brands Ltd. in May 2022. Ultra Brands Ltd. was incorporated in 2001 and is headquartered in Vancouver, Canada.
Nascent Biotech
OTCMKTS:NBIONascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. The company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. In addition, it develops CLNH5. The company has collaboration with Hypospray Pharma to develop an alternative delivery mechanism for patients who can benefit from Pritumumab. Nascent Biotech, Inc. is based in North Palm Beach, Florida.